Mr. Chaplin joined Bavarian Nordic in 1999. He was appointed executive vice president in 2004 and President & CEO in 2014. Prior to joining the Company, Mr. Chaplin worked for several years both in the UK and Australia developing vaccines against infectious diseases. Mr. Chaplin holds a Ph.D. in Immunology from Bristol University, and he is the general manager of Bavarian Nordic GmbH. He is a British national, born in 1967.
Mr. Larsen joined Bavarian Nordic in 2008 from Nordisk Film where he was CFO. Mr. Larsen holds an M.Sc. in economics and business administration from Copenhagen Business School, and he is a Danish national, born in 1965.
Mr. Birk joined Bavarian Nordic in 2008 from Coloplast where he held various management positions focusing on supply chain and production. Since joining Bavarian Nordic, he has served in positions of increasing responsibility, most recently as Senior Vice President, Strategy, People and Organization. Mr. Birk holds a Masters of Business Administration from Henley Business School, and he is a Danish national, born in 1974.
Mr. Kainu joined Bavarian Nordic in 2017 from Boston Consulting Group where he served for almost two decades, most recently as Partner and Managing Director. Prior to BCG, Dr. Kainu worked at the National Institutes of Health (USA) in the Cancer Genetics Branch of the National Human Genome Research Institute. Mr. Kainu obtained his MD and PhD degrees from the University of Tampere Medical School in Tampere, Finland. He is a Finnish National, born in 1973.